Table 2. Comparison of KRAS mutation analysis in FFPE EUS-FNA by dPCR and surgically resected tissue by Sanger sequencing^a.

		dPCR in EUS-FNA FFPE sections
	KRAS mutation status	WT	G12V or G12Db (1 mutation)	G12V and G12D (2 mutations)
Sanger sequencing in surgically resected tissues	WT	1	0	0
	G12V or G12D (1 mutation)	0	22	4
	G12V and G12D (2 mutations)	0	0	1

^aCytologically benign samples are excluded from this table as none of these patients underwent surgical resection

^bKRAS mutation subtypes matched between dPCR and Sanger sequencing for all patients in this category

Abbreviations: dPCR; digital PCR, WT; wild-type